A close-up eye with iris colours transitioning through brown, hazel, green and blue, returning to brown.

FLORetina-ICOOR 2026

3–6 DecemberFlorence, Italy

From retinal imaging to trial-ready evidence.

Imaging precision. Functional insight.
Expertise across your retina trial.

Connect with OIRRC in Florence to align retinal structure, visual function, and change over time—with expert-led imaging workflows from protocol design to the final read.

For sponsors, CROs, investigators, and retina research partners.

Scientific depthStructure + function + changeExpert-led endpoint strategy
Human oversightAI-powered, human-verifiedExpert review and adjudication
Multimodal imagingVendor-neutral by designConnected retinal imaging
Trial executionFrom protocol to final readSponsor-visible trial workflows

Trusted by leading innovators

Ora
Heidelberg Engineering
Complement Therapeutics
iCare
Sierra Clinical Services
Belite Bio
Topcon Healthcare
Boehringer Ingelheim

OIRRC science at FLORetina-ICOOR 2026

Sessions from our Scientific Team.
Explore the science.

Invited sessions

8 sessions · All times CET (Florence)

Session 01

3:15 PM – 4:30 PM

Symposium (EVERADS): Further Progress on Suprachoroidal Delivery for Ocular Therapeutics

Santo Spirito Room

Dr. Quan Dong NguyenLinkedIn ↗

Organizer & Speaker

Adeno-associated Virus Vector VV-14295 in Adults with Geographic Atrophy: the VISION Study

Session 02

4:30 PM – 5:45 PM

Innovations from the Byers Eye Institute at Stanford

Santo Spirito Room

Dr. Quan Dong NguyenLinkedIn ↗

Organizer & Moderator

Dr. Yasir SepahLinkedIn ↗

The Geography of Vision Loss: Why OCTA-guided Microperimetry May Redefine Functional Assessment in Ischemic Retinopathy

Session 03

10:45 AM – 11:30 AM

Clinical Trials

Campo Marzio Room

Dr. Yasir SepahLinkedIn ↗

Pre Screening for Retina Trials: A Human in the Loop AI Pipeline Across GA, Wet-AMD, DR, and Stargardt

Session 04

2:30 PM – 3:30 PM

Retinal Vascular Occlusions

San Giovanni Room

Dr. Yasir SepahLinkedIn ↗

The Geography of Vision Loss: Why OCTA-guided Microperimetry May Redefine Functional Assessment in Ischemic Retinopathy — Findings from the FLAME Study

Session 05

5:00 PM – 6:15 PM

Geographic Atrophy: Functional Biomarkers and Clinical Endpoints

San Lorenzo Room

Dr. Yasir SepahLinkedIn ↗

What Anatomy Misses: Image Guided Microperimetry as a Sensitive Functional Endpoint in Retinal Disease: Learnings from the OREO and GAZE Studies

Session 06

8:00 AM – 9:00 AM

Tumor Diagnosis and Prognosis (Ocular Oncology Diagnosis)

San Lorenzo Room

Dr. Yasir SepahLinkedIn ↗

On-Device AI for Ultrawidefield Imaging to Flag Referable Ocular Melanoma

Session 07

9:00 AM – 10:15 AM

Implementing AI in Retina and Posterior Segment Diseases: Triumphs and Challenges (SAIVO)

Campo Marzio Room

Dr. Yasir SepahLinkedIn ↗

Automated, Point-of-Care, Triage of Choroidal Lesions on Ultra-Widefield Imaging: A Human-in-the-Loop Deep Learning Model for Detecting High Risk Referable Melanoma

Session 08

6:00 PM – 6:45 PM

Geographic Atrophy – Retina Futura Spotlight: Emerging Therapies

San Giovanni Room

Dr. Yasir SepahLinkedIn ↗

Observations From OPTI-GAIN, a Phase 1/2 Study of Subretinal CTx001 for GA: Safety and Multimodal Efficacy in the Dose-Escalation Cohorts

Abstract presentations

7 presenters · 9 presentations

Oral presentation

Dr. Amir Hariri

LinkedIn ↗
  • Stargardt disease · Imaging biomarkers

    Predictive value of infrared imaging for estimating ellipsoid zone loss in Stargardt disease clinical trials

Oral presentation

Dr. Ali Sadiq

LinkedIn ↗
  • AMD · Structure–function

    Function Before Structure in Age-Related Macular Degeneration: Stimulus-Level Image-Guided Microperimetry Predicts Future Photoreceptor and RPE Loss

Oral · 2 presentations

Zawar Khan

LinkedIn ↗
  • Geographic atrophy · AI segmentation

    Dual-encoder deep learning segmentation of the photoreceptor-RPE zone in geographic atrophy using OCT and line-matched near-infrared reflectance

  • Diabetic macular edema · AI segmentation

    Automated segmentation of intraretinal fluid, subretinal fluid and pigment epithelial detachment on Spectralis OCT in diabetic macular edema: independent test set evaluation

Oral · 2 presentations

Dr. Isabel Sendino

LinkedIn ↗
  • Neovascular AMD · Real-world evidence

    Prospective real-world comparison of aflibercept 8 mg and faricimab in treatment-naive nAMD

  • Myopia · Quantitative OCT

    Morphological characteristics of perforating scleral vessels in myopic patients: a quantitative OCT analysis

Poster

Dr. Liz Zapata

LinkedIn ↗
  • Geographic atrophy & inherited retinal dystrophy · Structure–function

    Stimulus-scale independence of structure-function concordance in geographic atrophy and inherited retinal dystrophy: Goldmann III sampling is sufficient for image-guided microperimetry endpoints

Oral presentation

Sidrah Khan

LinkedIn ↗
  • Stargardt disease · Autofluorescence endpoints

    Beyond DDAF: automated threshold-based autofluorescence quantification makes total decreased autofluorescence a trial-ready endpoint in Stargardt disease

Video presentation

Dr. Tehmina Shehryar

LinkedIn ↗
  • Ocular oncology · Human-in-the-loop AI

    Ultrasound-free triage of choroidal melanocytic lesions: human-in-the-loop AI on ultra-widefield imaging estimates lesion height at the point of care

Our focus at FLORetina-ICOOR

Better imaging questions.
Stronger trial evidence.

At a meeting connecting retinal science, clinical practice, and innovation, OIRRC brings the imaging expertise to turn a study question into an executable plan.

FLORetina-ICOOR brings together medical and surgical retina with advanced imaging. EYENOVATE & Retina Futura Clinical Trials adds an innovation and clinical-development focus on 3 December.

01

Measure what
matters.

Align OCT, FAF, and other imaging modalities with the study question. Discuss endpoint definitions, atrophy measurement, and consistent assessment of retinal change over time.

Bring to the conversationAn endpoint, modality mix, or longitudinal analysis challenge.
02

Connect structure
with function.

Explore how image-guided microperimetry can connect retinal anatomy with local sensitivity, including research questions in geographic atrophy and Stargardt disease.

Bring to the conversationA structure–function question or functional testing strategy.
03

Move faster.
Keep experts in control.

Discuss earlier image-quality checks, AI-assisted review, and timely eligibility decisions, supported by qualified readers, adjudication, and a traceable workflow.

Bring to the conversationA screening bottleneck or an imaging workflow that needs clarity.

Purpose-built OIRRC technology

Scientific insight.
Connected execution.

Explore our technology

See more. Review with confidence.

ScopeAI brings image viewing, AI-assisted analysis, and structured review into a connected environment, with expert readers verifying clinically important decisions.

  • Multimodal image review
  • Image-quality flagging
  • Structured grading and adjudication
  • Human oversight and traceability
Discuss your review workflow
OIRRC retinal image viewerSelect image to enlarge ↗

One coordinated imaging partner

From the first study question
to the final read.

01 · PLAN

Define the imaging strategy

Align modalities, acquisition rules, eligibility criteria, and grading conventions with the study objective.

02 · PREPARE

Get sites trial-ready

Coordinate device qualification, photographer training, BCVA certification, and image-transfer workflows.

03 · REVIEW

Turn images into decisions

Combine quality checks, AI-assisted review, expert grading, dual reads, and adjudication.

04 · REPORT

Keep evidence traceable

Give sponsors visibility into status, queries, decisions, and documented outputs throughout the study.

<1 hour

From image to eligibility.Discuss OIRRC’s rapid, human-verified eligibility workflows and the requirements for your protocol.

Talk through your study

Connect with OIRRC in Florence

Bring your next
retina study into focus.

Planning a trial, refining an endpoint, or exploring a scientific collaboration? Request a conversation with OIRRC around FLORetina-ICOOR 2026.

Mention FLORetina 2026 when booking. Meeting time and location are confirmed with our team.

Congress
FLORetina-ICOOR 2026
Dates
3–6 December 2026Thursday through Sunday
Venue
Fortezza da BassoFlorence, Italy

OIRRC case study: Accelerating Eligibility with AI-Powered Imaging

OIRRC case study

See how imaging speed and oversight work together.

Learn how a global biotech sponsor shortened eligibility determination while preserving expert review, adjudication, and sponsor visibility.

1 hrEligibility
turnaround
DualRead +
adjudication
100%Workflow
visibility
Get the case study

Case study request

Get the case study.

Tell us a bit about your program and we will share the case study, along with the most relevant OIRRC follow-up for your retinal imaging and trial-execution priorities.

Loading the case study request form…

FLORetina-ICOOR 20263–6 December · FlorenceRequest a meeting
OIRRC platform

Original OIRRC product screenshot.